Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors.

Saved in:
Bibliographic Details
Title: Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors.
Authors: Veiga LHS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. veigal@mail.nih.gov., Gierach GL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Smith SA; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Howell RM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mille MM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Saha M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Curtis RE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Ramin C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Bodelon C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Department of Population Science, American Cancer Society, Atlanta, GA, USA., Feigelson HS; Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, CA, USA.; Institute for Health Research, Kaiser Permanente, Denver, CO, USA., Aiello Bowles EJ; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA., Buist DSM; Data-driven Strategies for Medicine & Biotechnology, Mercer Island, WA, USA.; University of Washington, Department of Health Systems and Population, School of Public Health, Seattle, WA, USA., Weinmann S; Kaiser Permanente Center for Health Research, Portland, OR, USA., Vo JB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Lee C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Berrington de Gonzalez A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK.
Source: British journal of cancer [Br J Cancer] 2026 Jan; Vol. 134 (2), pp. 269-278. Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-025-03240-w